In the future, we also hope to improve TGF-β3 drugs from the perspective of overall bone metabolism balance, hoping to provide some new treatment ideas for the treatment of diseases related to bone metabolism disorders. This evidence concerns the gene TGFB3 and metabolic bone disorder.